Deal Tracker · Companies

Duopharma Biotech deals

2 deals involving Duopharma Biotech (Malaysia) tracked by EPT across Southeast Asia, with partners including Biocon & Enimmune. Latest: Enimmune → Duopharma Biotech (Distribution, 15 Oct 2026).

Browse deals

By region

MENA (55) · GCC (53) · Africa (15) · Southeast Asia (14) · CIS & Central Asia (11) · Global (LMICs) (5) · Türkiye (4) · Global ex-US (1)

By deal type

Licensing (40) · Distribution (29) · Partnership / Collaboration (24) · Technology transfer / Localization (24) · M&A / Acquisition (17) · Equity / Investment (9) · Supply / Manufacturing (7) · Joint venture (6)

By company

ADCAN Pharma (11) · Mubadala Bio (8) · Hikma Pharmaceuticals (6) · Jamjoom Pharma (6) · Bio-Thera Solutions (5) · Department of Health – Abu Dhabi (4) · Avalon Pharma (4) · SPIMACO (4) · Kazakhstan Ministry of Health (4) · Groupe Saidal (4) · Roche (3) · Sanofi (3) · Taiba Healthcare (3) · Tabuk Pharmaceuticals (3) · Dar Al Dawa (3) · Galenicum (2) · DKSH (2) · Laprophan (2) · Adalvo (2) · Eva Pharma (2) · Rameda (2) · Menarini (2) · Korea United Pharm (2) · AstraZeneca (2) · MS Pharma (2) · LifePharma (2) · JCR Pharmaceuticals (2) · Gen İlaç (2) · Philex Pharmaceuticals (2) · Lotus Pharmaceutical (2) · Elpen (2) · Dhofar Pharmaceutical Industries (2) · CCL Pharmaceuticals (2) · Abdi İbrahim (2) · Nordic Pharma (2) · UNIMED Laboratories (2) · SaudiVax (2) · Biocon (2) · Novo Nordisk (2) · VACSERA (2) · Lifera (2) · Julphar (2)

By therapeutic area

Multi-therapy (39) · Metabolic / Diabetes (21) · Oncology (21) · Cardiovascular (13) · Vaccines (11) · Immunology / Inflammation (9) · Ophthalmology (5) · Infectious Disease (4) · Rare / Orphan (4) · CNS / Neurology (3) · Consumer health (3) · Women's Health (3) · Respiratory (2)